Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 2
1978 1
1979 1
1980 1
1981 4
1982 2
1983 3
1984 3
1985 4
1986 7
1987 4
1988 6
1989 10
1990 8
1991 11
1992 9
1993 5
1994 12
1995 6
1996 10
1997 11
1998 9
1999 11
2000 11
2001 8
2002 8
2003 10
2004 8
2005 13
2006 6
2007 20
2008 14
2009 20
2010 19
2011 12
2012 7
2013 7
2014 6
2015 4
2016 5
2017 4
2018 7
2019 6
2020 4
2021 4
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

326 results
Results by year
Filters applied: . Clear all
Page 1
The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.
Colunga Biancatelli RML, Solopov PA, Sharlow ER, Lazo JS, Marik PE, Catravas JD. Colunga Biancatelli RML, et al. Among authors: lazo js. Am J Physiol Lung Cell Mol Physiol. 2021 Aug 1;321(2):L477-L484. doi: 10.1152/ajplung.00223.2021. Epub 2021 Jun 22. Am J Physiol Lung Cell Mol Physiol. 2021. PMID: 34156871 Free PMC article.
Bleomycin.
Lazo JS, Sebti SM. Lazo JS, et al. Cancer Chemother Biol Response Modif. 1997;17:40-5. Cancer Chemother Biol Response Modif. 1997. PMID: 9551207 Review. No abstract available.
Bleomycin.
Lazo JS, Sebti SM. Lazo JS, et al. Cancer Chemother Biol Response Modif. 1994;15:44-50. Cancer Chemother Biol Response Modif. 1994. PMID: 7540032 Review. No abstract available.
Bleomycin.
Lazo JS. Lazo JS. Cancer Chemother Biol Response Modif. 1999;18:39-45. Cancer Chemother Biol Response Modif. 1999. PMID: 10800476 Review. No abstract available.
Bleomycins.
Lazo JS, Sebti SM. Lazo JS, et al. Cancer Chemother Biol Response Modif. 1991;12:51-8. Cancer Chemother Biol Response Modif. 1991. PMID: 1718378 Review. No abstract available.
Refining Radiation for the Next Century.
Lazo JS. Lazo JS. Mol Cancer Ther. 2018 Feb;17(2):332-335. doi: 10.1158/1535-7163.MCT-17-1244. Mol Cancer Ther. 2018. PMID: 29420296 No abstract available.
Drugging Undruggable Molecular Cancer Targets.
Lazo JS, Sharlow ER. Lazo JS, et al. Annu Rev Pharmacol Toxicol. 2016;56:23-40. doi: 10.1146/annurev-pharmtox-010715-103440. Epub 2015 Nov 2. Annu Rev Pharmacol Toxicol. 2016. PMID: 26527069 Review.
Small molecule targeting of PTPs in cancer.
Lazo JS, McQueeney KE, Burnett JC, Wipf P, Sharlow ER. Lazo JS, et al. Int J Biochem Cell Biol. 2018 Mar;96:171-181. doi: 10.1016/j.biocel.2017.09.011. Epub 2017 Sep 21. Int J Biochem Cell Biol. 2018. PMID: 28943273 Review.
Drug discovery algorithm for cutaneous leishmaniasis.
Grogl M, Hickman M, Ellis W, Hudson T, Lazo JS, Sharlow ER, Johnson J, Berman J, Sciotti RJ. Grogl M, et al. Among authors: lazo js. Am J Trop Med Hyg. 2013 Feb;88(2):216-21. doi: 10.4269/ajtmh.11-0812. Am J Trop Med Hyg. 2013. PMID: 23390221 Free PMC article. Review.
Is Cdc25 a druggable target?
Lazo JS, Wipf P. Lazo JS, et al. Anticancer Agents Med Chem. 2008 Dec;8(8):837-42. doi: 10.2174/187152008786847738. Anticancer Agents Med Chem. 2008. PMID: 19075566 Free PMC article. Review.
326 results